Neonatal and pediatric extracorporeal membrane oxygenation in developing Latin American countries

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2017
Editora
SOC BRASIL PEDIATRIA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
KATTAN, Javier
GONZALEZ, Alvaro
CASTILLO, Andres
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JORNAL DE PEDIATRIA, v.93, n.2, p.120-129, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To review the principles of neonatal-pediatric extracorporeal membrane oxygenation therapy, prognosis, and its establishment in limited resource-limited countries in Latino America. Sources: The PubMed database was explored from 1985 up to the present, selecting from highly indexed and leading Latin American journals, and Extracorporeal Life Support Organization reports. Summary of the findings: Extracorporeal membrane oxygenation provides ""time"" for pulmonary and cardiac rest and for recovery. It is used in the neonatal-pediatric field as a rescue therapy for more than 1300 patients with respiratory failure and around 1000 patients with cardiac diseases per year. The best results in short- and long-term survival are among patients with isolated respiratory diseases, currently established as a standard therapy in referral centers for high-risk patients. The first neonatal/pediatric extracorporeal membrane oxygenation Program in Latin America was established in Chile in 2003, which was also the first program in Latin America to affiliate with the Extracorporeal Life Support Organization. New extracorporeal membrane oxygenation programs have been developed in recent years in referral centers in Argentina, Colombia, Brazil, Mexico, PerU, Costa Rica, and Chile, which are currently funding the Latin American Extracorporeal Life Support Organization chapter. Conclusions: The best results in short- and long-term survival are in patients with isolated respiratory diseases. Today extracorporeal membrane oxygenation therapy is a standard therapy in some Latin American referral centers. It is hoped that these new extracorporeal membrane oxygenation centers will have a positive impact on the survival of newborns and children with respiratory or cardiac failure, and that they will be available for an increasing number of patients from this region in the near future. (C) 2016 Sociedade Brasileira de Pediatria.
Palavras-chave
Extracorporeal membrane oxygenation, ECMO, Respiratory failure, Cardiac failure, Pulmonary hypertension, ELSO
Referências
  1. Alvarado-Socarrás Jorge Luis, 2014, Arch. Cardiol. Méx., V84, P121, DOI 10.1016/j.acmx.2013.07.010
  2. Arens J, 2011, ARTIF ORGANS, V35, P997, DOI 10.1111/j.1525-1594.2011.01324.x
  3. Bae JO, 2005, J PEDIATR SURG, V40, P1051, DOI 10.1016/j.jpedsurg.2005.03.026
  4. Bartlett RH, 2012, ECMO EXTRACORPOREAL, P11
  5. Bennett CC, 2001, LANCET, V357, P1094, DOI 10.1016/S0140-6736(00)04310-5
  6. Bohn D, 2012, ECMO EXTRACORPOREAL, P41
  7. Caneo LF, 2016, ARTIF ORGANS, V40, P925, DOI 10.1111/aor.12816
  8. Caneo LF, 2015, REV BRAS CIR CARDIOV, V30, P657, DOI 10.5935/1678-9741.20150088
  9. Davis PJ, 2004, J PEDIATR-US, V144, P309, DOI 10.1016/j.jpeds.2003.11.031
  10. Dominguez ED, 2012, ARCH ARGENT PEDIATR, V110, P404, DOI [10.1590/S0325-00752012000500007, 10.5546/aap.2012.xxx]
  11. El-Ferzli GT, 2009, PEDIATR RES, V66, P671, DOI 10.1203/PDR.0b013e3181bbbf7a
  12. El-Ferzli GT, 2009, PEDIATR RES, V66, P677, DOI 10.1203/PDR.0b013e3181bbc7ec
  13. ELSO Data Registry, 2016, ECMO REG EXTR LIF SU
  14. Florez Claudia X, 2015, World J Pediatr Congenit Heart Surg, V6, P374, DOI 10.1177/2150135115589788
  15. Fortenberry J., 2012, ECMO EXTRACORPOREAL, P1
  16. Haines NM, 2009, ASAIO J, V55, P111, DOI 10.1097/MAT.0b013e318190b6f7
  17. Hamutcu R, 2004, PEDIATRICS, V114, P1292, DOI 10.1542/peds.2003-1080-L
  18. Karimova A, 2009, ARCH DIS CHILD-FETAL, V94, pF129, DOI 10.1136/adc.2008.141051
  19. Kattan J, 2011, 8 C IB NEON SOC IB N
  20. Kattan J, 2013, PEDIATR CRIT CARE ME, V14, P876, DOI 10.1097/PCC.0b013e318297622f
  21. Kattan J, 2010, PEDIATR SURG INT, V26, P671, DOI 10.1007/s00383-010-2624-3
  22. Kattan JS, 2005, REV MED CHILE, V133, P1065, DOI 10.4067/S0034-98872005000900010
  23. Keller RL, 2013, PEDIATR CRIT CARE ME, V14, P900, DOI 10.1097/PCC.0b013e31829f6008
  24. Kinsella JP, 1997, J PEDIATR-US, V131, P55, DOI 10.1016/S0022-3476(97)70124-0
  25. Kossel H, 2000, INTENS CARE MED, V26, P1489, DOI 10.1007/s001340000603
  26. McNally H, 2006, PEDIATRICS, V117, pE845, DOI 10.1542/peds.2005-1167
  27. Miana LA, 2015, REV BRAS CIR CARDIOV, V30, P409, DOI 10.5935/1678-9741.20150053
  28. Moreno Guillermo E., 2014, Arch. Cardiol. Méx., V84, P256, DOI 10.1016/j.acmx.2013.12.009
  29. Morini F, 2006, EUR J PEDIATR SURG, V16, P385, DOI 10.1055/s-2006-924751
  30. Mugford M, 2008, COCHRANE DB SYST REV, V3, DOI 10.1002/14651858.CD001340.PUB2
  31. Ogino MT, 2012, ECMO EXTRACORPOREAL, P479
  32. Paden ML, 2014, SEMIN PERINATOL, V38, P65, DOI 10.1053/j.semperi.2013.11.002
  33. Pawlik TD, 2009, PEDIATRICS, V123, pE17, DOI 10.1542/peds.2007-3566
  34. Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2
  35. Petrou S, 2006, PEDIATRICS, V117, P1640, DOI 10.1542/peds.2005-1150
  36. Segura S, 2009, AN PEDIATR, V70, P12, DOI 10.1016/j.anpedi.2008.08.011
  37. Short BL, 2008, J PERINATOL, V28, pS79, DOI 10.1038/jp.2008.152
  38. Smalley N, 2012, INTENS CARE MED, V38, P1001, DOI 10.1007/s00134-012-2581-5
  39. Stoffan AP, 2012, J PEDIATR SURG, V47, P1053, DOI 10.1016/j.jpedsurg.2012.03.004
  40. Thiagarajan RR, 2012, ECMO EXTRACORPOREAL, P33
  41. UK Collaborative ECMO Trial Group, 1996, LANCET, V348, P75
  42. Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481
  43. Zabrocki LA, 2011, CRIT CARE MED, V39, P364, DOI 10.1097/CCM.0b013e3181fb7b35